Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Sahand Golpayegany"'
Autor:
Daniel B. Chastain, Sahand Golpayegany, Andrés F. Henao-Martínez, Brittany T. Jackson, Laura Leigh Stoudenmire, Kaye Bell, Kayla R. Stover, Carlos Franco-Paredes
Publikováno v:
Therapeutic Advances in Infectious Disease, Vol 9 (2022)
While overall survival with multiple myeloma (MM) has improved, patients suffer from overwhelming tumor burden, MM-associated comorbidities, and frequent relapses requiring administration of salvage therapies. As a result, this vicious cycle is often
Externí odkaz:
https://doaj.org/article/a7ea1b7becdf4b3497569bdf463cd956
Autor:
Daniel B. Chastain, Vanessa M. Kung, Lilian Vargas Barahona, Brittany T. Jackson, Sahand Golpayegany, Carlos Franco-Paredes, George R. Thompson, Andrés F. Henao-Martínez
Publikováno v:
Journal of Fungi, Vol 8, Iss 11, p 1234 (2022)
The effect of COVID-19 on the risk and prognosis of cryptococcosis is unclear. We compared the characteristics and outcomes of cryptococcosis in patients with and without COVID-19. Patients 18 years and older with cryptococcosis were identified from
Externí odkaz:
https://doaj.org/article/cf72d7dca51947228e39e880f86db7fd
Autor:
Daniel B. Chastain, Vanessa M. Kung, Sahand Golpayegany, Brittany T. Jackson, Carlos Franco‐Paredes, Lilian Vargas Barahona, George R. Thompson, Andrés F. Henao‐Martínez
Publikováno v:
Mycoses. 65:815-823
It is unclear if there is an association between COVID-19 and cryptococcosis. Therefore, this study aimed to describe the clinical features, risk factors, and outcomes associated with cryptococcosis in hospitalised patients with COVID-19. The objecti
Autor:
Daniel B Chastain, Vanessa Kung, Sahand Golpayegany, Brittany T Jackson, Carlos Franco-Paredes, George R Thompson, Andrés F Henao-Martínez
Publikováno v:
Open Forum Infectious Diseases. 9
Background It remains unclear if there is an association between COVID-19 and cryptococcosis. The purpose of this study was to compare demographic characteristics and outcomes of cryptococcosis between patients with COVID-19 to non-COVID-19 controls.